MS News That Caught My Eye Last Week: COVID-19 Vaccines, Achtar Gel, Ublituximab, Pregnancy

MS News That Caught My Eye Last Week: COVID-19 Vaccines, Achtar Gel, Ublituximab, Pregnancy

314659

MS News That Caught My Eye Last Week: COVID-19 Vaccines, Achtar Gel, Ublituximab, Pregnancy

Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines This research adds more evidence to studies that have already shown that certain disease-modifying therapies reduce the effectiveness of COVID-19 vaccines. Those DMTs include Kesimpta (ofatumumab) and Ocrevus (ocrelizumab), plus rituximab, another anti-CD20 vaccine, that is sometimes used off-label to treat MS. But keep in mind that any protection against the SARS CoV-2 virus is better than none, and multiple sclerosis (MS) groups around the world…

You must be logged in to read/download the full post.